Impact BioMedical Inc. (IBO) stock
IBONYSEPharmaceutical PreparationsFiscal year ends December 31
$3.06+0.38 (+14.18%)
Close on Oct 19, 2026Market cap $26.14MP/E –Yield –
Impact BioMedical enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Impact BioMedical's enterprise value was $29.28M on Oct 19, 2026, against $2.85M a year earlier. Over the last 2 years it ranged from $1.37M to $50.90M, with a median of $4.78M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Oct 19, 2026 | $29.28M | +753.8% |
| 2025 | Dec 31, 2025 | $3.43M | -64.4% |
| 2024 | Dec 31, 2024 | $9.62M | – |
See a number that looks wrong?